1. Acute intraprocedural thrombosis during an arterial ductal stenting successfully managed by eptifibatide
- Author
-
Zeeshan Ahmed Mumtaz and Kothandam Sivakumar
- Subjects
medicine.medical_specialty ,Eptifibatide ,Arterial duct ,Platelet membrane glycoprotein ,Fibrinolytic Agents ,Internal medicine ,Occlusion ,medicine ,Humans ,Thrombolytic Agent ,Platelet ,cardiovascular diseases ,Thrombus ,business.industry ,Infant, Newborn ,Thrombosis ,General Medicine ,medicine.disease ,Pediatrics, Perinatology and Child Health ,Cardiology ,Stents ,Cardiology and Cardiovascular Medicine ,business ,Platelet Aggregation Inhibitors ,medicine.drug - Abstract
Acute stent thrombosis may complicate neonatal arterial duct stenting for reduced pulmonary blood flow. Thrombolytic agents recanalise the clot but may cause bleeding around the vascular sheaths and other sites. Since early thrombus is platelet mediated, intravenous platelet glycoprotein inhibitor like eptifibatide is likely to be effective, but rarely utilised in neonates. Ductal stent thrombosis treated with eptifibatide is reported.
- Published
- 2021
- Full Text
- View/download PDF